Sutro Biopharma Inc (STRO)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO, CA 94080

Sutro Biopharma, Inc. develops and manufactures pharmaceutical products. The Company provides antibody drug conjugate and multi-specific antibody-based therapeutics for cancer therapy. Sutro Biopharma serves the pharmaceutical industries throughout the United States.

Data as of 2021-05-08 11:58:54 -0400
Market Cap889.341 Million Shares Outstanding46.104 Million Avg 30-day Volume333.128 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-8.18 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.76916 52-week High/Low28.3 / 7.06 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from STRO instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 2 50.0% 2 (0.12%) 2 (0.12%) 0.0%
Funds Holding: 130 86 51.16% 61 (3.66%) 38 (2.36%) 60.53%
13F shares: 39.205 Million 30.543 Million 28.36% 22.144 Million 20.198 Million 9.63%
% Ownership 85.9616 85.1286 0.98% 48.5541 56.296 -13.75%
New Positions: 57 18 216.67% 29 10 190.0%
Increased Positions 45 39 15.38% 17 14 21.43%
Closed Positions 13 11 18.18% 6 6 0.0%
Reduced Positions 17 16 6.25% 11 8 37.5%
Total Calls 52.961 Thousand
Total Puts 31.934 Thousand
PUT/CALL Ratio 0.6
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding STRO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding STRO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HALLAM TREVOR PRES. RSRCH & CF. SCTIFIC OFCR

  • Officer
35,000 2021-04-16 14

ALBINI EDWARD C CFO AND SECRETARY

  • Officer
85,000 2021-03-05 3

SHABBIR ANIK CHIEF TECHNICAL OPS. OFFICER

  • Officer
85,000 2021-03-05 3

FITZPATRICK LINDA A CHIEF PEOPLE & COMM. OFFICER

  • Officer
85,000 2021-03-05 5

NEWELL WILLIAM J CEO

  • Officer
  • Director
275,000 2021-03-05 4

MOLINA ARTURO MD CHIEF MEDICAL OFFICER

  • Officer
110,000 2021-03-05 4

PETREE DANIEL H

  • Director
8,180 2021-01-26 2

FREUND JOHN GORDON

  • Director
56,327 2020-12-10 6

WIGGINTON JON MARC

  • Director
0 2020-11-30 2

DYBBS MICHAEL

  • Director
0 2020-06-05 1

LOBACKI JOSEPH M

  • Director
0 2020-06-05 1

SHARP SHALINI

  • Director
0 2020-06-05 1

MATSUI CONNIE

  • Director
0 2020-06-05 1

PANEK JAMES P

  • Director
0 2020-06-05 1

JANNEY DANIEL

  • Director
0 2019-06-17 0

WORSLEY STEPHEN CHIEF BUSINESS OFFICER

  • Officer
0 2019-01-29 0

MERCK & CO., INC.

MERCK SHARP & DOHME CORP.

  • 10% Owner
2,723,509 2018-10-01 0

ALTA PARTNERS VIII, L.P.

ALTA PARTNERS MANAGEMENT VIII, LLC

CHAMPSI FARAH

JANNEY DANIEL

NOHRA GUY P

  • Director
  • 10% Owner
No longer subject to file 2018-10-01 0

SKYLINE VENTURE PARTNERS V LP

SKYLINE VENTURE MANAGEMENT V, LLC

KANEKO YASUNORI

  • 10% Owner
1,960,053 2018-10-01 0

CELGENE CORP /DE/

No longer subject to file 2018-10-01 0

SVLSF V, LLC

ILSF III, LLC

INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P.

INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P.

INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P.

INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P.

SV LIFE SCIENCES FUND V (GP), LP

SV LIFE SCIENCES FUND V LP

SV LIFE SCIENCES FUND V STRATEGIC PARTNERS, L.P.

  • 10% Owner
No longer subject to file 2018-09-27 0

ROSS MICHAEL JAY

  • Director
  • 10% Owner
1,824,542 2018-09-27 0

LAWLIS V BRYAN

  • Director
2,478 2018-09-26 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HALLAM TREVOR - Officer PRES. RSRCH & CF. SCTIFIC OFCR

2021-04-20 17:38:55 -0400 2021-04-16 A 20,000 a 20,000 direct

HALLAM TREVOR - Officer PRES. RSRCH & CF. SCTIFIC OFCR

2021-04-20 17:38:55 -0400 2021-04-16 A 15,000 a 15,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SUTRO BIOPHARMA INC STRO 2021-05-11 22:15:03 UTC -0.3581 0.4081 700000
SUTRO BIOPHARMA INC STRO 2021-05-11 21:45:03 UTC -0.3581 0.4081 700000
SUTRO BIOPHARMA INC STRO 2021-05-11 21:15:03 UTC -0.3581 0.4081 700000
SUTRO BIOPHARMA INC STRO 2021-05-11 20:45:03 UTC -0.3581 0.4081 700000
SUTRO BIOPHARMA INC STRO 2021-05-11 20:15:03 UTC -0.3581 0.4081 700000
SUTRO BIOPHARMA INC STRO 2021-05-11 19:45:03 UTC -0.3581 0.4081 700000
SUTRO BIOPHARMA INC STRO 2021-05-11 19:15:02 UTC -0.3581 0.4081 700000
SUTRO BIOPHARMA INC STRO 2021-05-11 18:45:02 UTC -0.3581 0.4081 700000
SUTRO BIOPHARMA INC STRO 2021-05-11 18:15:03 UTC -0.3581 0.4081 700000
SUTRO BIOPHARMA INC STRO 2021-05-11 17:45:03 UTC -0.3581 0.4081 700000
SUTRO BIOPHARMA INC STRO 2021-05-11 17:15:04 UTC -0.3581 0.4081 700000
SUTRO BIOPHARMA INC STRO 2021-05-11 16:45:04 UTC -0.3581 0.4081 700000
SUTRO BIOPHARMA INC STRO 2021-05-11 16:15:04 UTC -0.3581 0.4081 700000
SUTRO BIOPHARMA INC STRO 2021-05-11 15:45:03 UTC -0.3581 0.4081 700000
SUTRO BIOPHARMA INC STRO 2021-05-11 15:15:03 UTC -0.3581 0.4081 700000
SUTRO BIOPHARMA INC STRO 2021-05-11 14:45:03 UTC -0.3581 0.4081 700000
SUTRO BIOPHARMA INC STRO 2021-05-11 14:15:03 UTC -0.3581 0.4081 700000
SUTRO BIOPHARMA INC STRO 2021-05-11 13:45:04 UTC -0.3581 0.4081 700000
SUTRO BIOPHARMA INC STRO 2021-05-11 13:15:04 UTC -0.3581 0.4081 700000
SUTRO BIOPHARMA INC STRO 2021-05-11 12:45:03 UTC -0.3581 0.4081 700000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments